This study is currently not recruiting participants.

The Utility of Endoscopic Ultrasound (EUS)-Fine Needle Aspiration (FNA) for the Diagnosis of Pancreatic Cystic Neuroendocrine Tumors (PCNETs): A Decade of Single Center Experience

Investigation of EUS-FNA in Diagnosing PCNETs

Not Recruiting
100 years or below
All
Phase N/A
1 Location

Brief description of study.

This retrospective study will aim at describing the EUS and FNA characteristics of PCNETs, in order to study the utility of EUS-FNA in the diagnosis of PCNETs.

Detailed description of study

This retrospective study will aim at describing the EUS and FNA characteristics of PCNETs, in order to study the utility of EUS-FNA in the diagnosis of PCNETs.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Pancreatic Cancer
  • Age: 100 years or below
  • Gender: All

This study investigates the characteristics of pancreatic neuroendocrine tumors (PCNETs) using endoscopic ultrasound (EUS) and fine-needle aspiration (FNA). The purpose of this study is to understand how EUS-FNA can be used to diagnose PCNETs effectively.

Participants will undergo procedures involving EUS and FNA, which are techniques used to visualize and sample tissues from the pancreas. Endoscopic ultrasound involves using a special scope to see inside the body, while fine-needle aspiration involves taking a small sample of tissue using a thin needle.

  • Who can participate: Individuals aged 18 and older with suspected pancreatic neuroendocrine tumors may be eligible to participate. Key eligibility criteria include no prior treatment for PCNETs and the ability to undergo EUS and FNA procedures.
  • Study details: Participants will undergo EUS and FNA procedures to help researchers study the characteristics of PCNETs. Participants will not receive any investigational medication or placebo as part of this study.
Updated on 19 Feb 2024. Study ID: 1307011784

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team